JPM holder to sell 5,731 shares, $1.76M value

JPM common stock holder Mary Erdoes filed a notice to sell 5,731 shares of common stock, with an aggregate market value of $1,756,045.86, through J.P.

Rhea-AI Filing Summary

JPM common stock holder Mary Erdoes filed a notice to sell 5,731 shares of common stock, with an aggregate market value of $1,756,045.86, through J.P. Morgan Securities LLC on or about 02/17/2026 on the NYSE. The filing lists 2,696,272,576 common shares outstanding.

The 5,731 shares to be sold were acquired on 01/13/2026 as equity compensation awards from the issuer. Over the prior three months, Erdoes sold 5,732 shares of the same common stock on 01/16/2026 for gross proceeds of $1,792,878.56.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the JPM Form 144 filing by Mary Erdoes disclose?

The Form 144 discloses that shareholder Mary Erdoes intends to sell 5,731 shares of JPM common stock. The planned sale has an aggregate market value of $1,756,045.86 and is to be executed through J.P. Morgan Securities LLC on the NYSE.

How many JPM shares is Mary Erdoes planning to sell under this notice?

The notice covers a proposed sale of 5,731 shares of JPM common stock. These shares were acquired on January 13, 2026 as equity compensation awards from the issuer, and are to be sold through J.P. Morgan Securities LLC on the NYSE.

What is the approximate value of the JPM shares in Mary Erdoes’ planned sale?

The filing shows an aggregate market value of $1,756,045.86 for the 5,731 JPM common shares to be sold. This value is based on market pricing at the time of the notice and relates specifically to this proposed NYSE transaction.

When were the JPM shares to be sold by Mary Erdoes originally acquired?

The 5,731 JPM shares were acquired on January 13, 2026. The acquisition is described as resulting from awards granted by the issuer, categorized as equity compensation, with the same date listed for both acquisition and payment.

Has Mary Erdoes sold JPM shares in the last three months?

Yes. The filing reports that 5,732 JPM common shares were sold on January 16, 2026. Those shares generated gross proceeds of $1,792,878.56, and this prior sale is disclosed as part of the three-month transaction history requirement.

How many JPM common shares are outstanding according to this Form 144?

The Form 144 lists 2,696,272,576 JPM common shares outstanding. This figure provides a baseline for understanding the scale of the proposed 5,731-share sale relative to the issuer’s total common stock base at the time of the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 05:16 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001473446
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JPMORGAN CHASE & CO.
SEC File Number	001-05805
Address of Issuer	270 Park Avenue New York NEW YORK 10017
Phone	2122702978
Name of Person for Whose Account the Securities are To Be Sold	Mary E. Erdoes
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	CEO, Asset & Wealth Management

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Avenue New York NY 10017-2014	5731	1756045.86	2696272576	02/17/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock. $1 Par Value	01/13/2026	Acquired as a result of awards granted by Issuer	Issuer			5731	01/13/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mary Erdoes c/o J.P. Morgan Securities LLC 270 Park Avenue New York NY 10017-2014	Common Stock. $1 Par Value	01/16/2026	5732	1792878.56

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/01/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Holly Youngwood under POA on behalf of Mary E. Erdoes
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)